首页> 中文期刊>中国医药导报 >对肺癌合并肺毛霉菌感染患者的药学监护

对肺癌合并肺毛霉菌感染患者的药学监护

     

摘要

目的 探讨肺癌合并肺毛霉菌感染患者的药学监护及不良反应监测,探索临床药学实践方法.方法 对1例肺癌合并肺毛霉菌感染的患者提供了用药分析、给药剂量的换算及药物不良反应监测等多种药学监护.结果 通过此病例,临床药师对肺毛霉菌的诊断、治疗及预后积累了更多经验,对药物治疗的使用及不良反应的监测有了深刻体会.结论 临床药师在药学实践中应兼顾药物的安全和有效,真正的做一名合理用药的参与者.%Objective To study the lung cancer patients with pulmonary fungus infection rhizopus oryzae, pharmaceutical care and adverse reaction monitoring, exploring the clinical pharmacists pharmacy practice method. Methods 1 case of lung cancer with pulmonary fungus infection rhizopus oryzae patients with analysis of the drug, drug doses of conversion and adverse drug reaction monitoring had multiple pharmaceutical care. Results Through this case, the clinical pharmacists had more experience to rhizopus oryzae of diagnosis, treatment and prognosis, having accumulated valuable experience in the medical treatment use and adverse reaction monitoring. Conclusion Clinical pharmacists in pharmacy practice should consider both safe and effective drugs,and really do a rational drug use of participants.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号